Document is current

Article History

Received: 6 November 2025

Accepted: 15 December 2025

First Online: 22 December 2025

Declarations

:

: Isabelle Opitz: Roche (Institutional Grant), AstraZeneca (Advisory Board and Steering Committee), MSD (Advisory Board), BMS (Advisory Board), Medtronic (Institutional Grant and Advisory Board), Intuitive (Proctorship and Speakers Fee), Sanofi (Speakers Fee), Regeneron (Advisory Board), XVIVO (Institutional Grant), Siemens (Speakers Fee), Astellas (Speakers Fee). IO is IASLC Board Director, Member of the Thoracic Clinical Practice Standards Committee and the Thoracic Education Committee of AATS, iMig Board Member and JTCVS Associate Editor. She is in the Stiftungsrat Schulthessklinik and an Advisory Board Member at Med Uni Wien for Comprehensive Center for Chest Diseases (CCCD).Michael Weller has received research grants from Novartis, Quercis and Versameb, and honoraria for lectures or advisory board participation or consulting from Nuvation, Bayer, Curevac, Hemerion, Iqvia, Medac, Novartis, Novocure, Orbus, Pfizer, Philogen, Roche and Servier.Emilie Le Rhun has received research grants from Bristol Meyers Squibb (BMS) and Servier, and honoraria for lectures or advisory board participation or consulting from Bayer, Biodexa / Sitoxi, Janssen, Leo Pharma, Medac, My Tomorrows, Pierre Fabre, Roche, Seattle Genetics and Servier.